Serum prostate-specific antigen levels in older men with or at risk of HIV infection.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2435169)

Published in HIV Med on October 01, 2006


L E Vianna1, Y Lo, R S Klein

Author Affiliations

1: Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA.

Articles citing this ↘

Urologic complications of HIV and AIDS. Nat Clin Pract Urol (2009) 0.76

Articles cited by this ↗

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med (2004) 15.10

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst (2000) 3.47

Epidemiology of prostate cancer. Urology (2003) 2.91

Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer (1995) 2.82

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis (2004) 2.42

Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol (1990) 2.21

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98

Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96

Cancer risk in patients on dialysis and after renal transplantation. Lancet (2000) 1.87

To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med (2004) 1.74

Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72

Cancer in older persons: an international issue in an aging world. Semin Oncol (2004) 1.71

Age-specific reference ranges for serum PSA. N Engl J Med (1996) 1.61

High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis (2004) 1.39

Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr (2004) 1.24

Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23

AIDS-associated cancer in developing nations. Curr Opin Oncol (2004) 1.08

Diet and prostate cancer. Toxicology (2002) 1.07

The epidemiology of prostate cancer part I: descriptive epidemiology. Semin Urol Oncol (1998) 1.05

Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann Epidemiol (2001) 1.04

AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer (2001) 1.01

Update on screening for prostate cancer with prostate-specific antigen. Crit Rev Oncol Hematol (2004) 0.98

Prostate cancer after heart transplantation. J Urol (1995) 0.97

Immunosurveillance and cancer: epidemiologic observations. Natl Cancer Inst Monogr (1977) 0.97

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Cancer incidence in patients on chronic dialysis and in renal transplant recipients. Urol Int (1990) 0.92

Human retroviruses: their role in cancer. Proc Assoc Am Physicians (2000) 0.91

Aging biology and cancer. Semin Oncol (2004) 0.91

Pathologic aspects of AIDS malignancies. Oncogene (2003) 0.88

Prostate carcinoma among men with human immunodeficiency virus infection. Cancer (2004) 0.88

Prostate cancer in HIV infection. AIDS (1996) 0.87

Screening for prostate cancer: current recommendations. Urol Clin North Am (2004) 0.85

Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular Surgery. Urology (1998) 0.84

Increased incidence of pathological and clinical prostate cancer with age: age related alterations of local immune surveillance. J Urol (2004) 0.79

Increased risk of prostate cancer in HIV infection? AIDS (2002) 0.79

Radical retropubic prostatectomy after orthotopic liver transplantation. Urology (2005) 0.77

AIDS-related tumors: integrating antiviral and anticancer therapy. Crit Rev Oncol Hematol (2002) 0.77

Articles by these authors ⇆

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11

Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76

Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72

Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17

Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15

Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86

Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51

Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41

Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36

The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30

Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23

Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20

High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19

Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06

Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92

Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77

Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75

Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69

Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63

Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54

A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54

Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51

An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51

Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47

Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47

Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol (2009) 1.46

Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40

High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39

Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36

Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30

The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29

Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23

Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23

Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22

A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17

Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16

Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11

High testicular salvage rate in torsion of the spermatic cord. J Urol (1982) 1.11

A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11

Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (2001) 1.10

Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10

Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08

The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide. J Neurosci (1997) 1.07

Lack of association of Streptococcus bovis with noncolonic gastrointestinal carcinoma. Am J Gastroenterol (1987) 1.06

Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06

Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05

Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis (1987) 1.05

Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer (1994) 1.03

An effective hospital-based pneumococcal immunization program. Arch Intern Med (1986) 1.02

A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02

Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01

A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01

Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.00

The effect of heterogeneous infectious period and contagiousness on the dynamics of Salmonella transmission in dairy cattle. Epidemiol Infect (2008) 1.00

Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother (1986) 1.00

Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis (1998) 1.00

Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99

Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health (1999) 0.99

Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection. J Infect Dis (2000) 0.98

Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med (2006) 0.97

The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2001) 0.97

Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol (1991) 0.96

Carcinoma of the colon 2 years after endocarditis due to Streptococcus bovis. Am J Gastroenterol (1983) 0.96

Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis (2003) 0.96

Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome. J Immunol (1985) 0.95

Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats. Antimicrob Agents Chemother (1994) 0.95

Nucleosides. 78. Synthesis of some 6-substituted uracils and uridines by the Wittig reaction. J Org Chem (1972) 0.95

Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS (1990) 0.95

Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients. Ophthalmology (1983) 0.94

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS (1999) 0.93

Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem (1983) 0.93

Prevention of postoperative nausea and vomiting after intrathecal morphine for Cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. Int J Obstet Anesth (2007) 0.93

Rates of and factors associated with self-reported prior HIV testing among adult medical patients in an inner city emergency department in the Bronx, New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92

Ventricular excitation maps using tissue Doppler acceleration imaging: potential clinical application. J Am Coll Cardiol (1999) 0.91

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring. J Antimicrob Chemother (2012) 0.91

Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA (1986) 0.91

Body image in older men with or at-risk for HIV infection. AIDS Care (2007) 0.90

Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med Oncol (1999) 0.90

Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS (2001) 0.89

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. Am J Med (1998) 0.89

Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes Immun (2002) 0.88

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med (2006) 0.88

Haemophilus parainfluenzae septic arthritis in an adult. JAMA (1981) 0.88

Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr (2000) 0.87

Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1989) 0.87

Major aphthous-like ulcers in patients with AIDS. Oral Surg Oral Med Oral Pathol (1991) 0.86

Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection. Clin Exp Immunol (1988) 0.86

Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis. Antimicrob Agents Chemother (1987) 0.86

Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev (1995) 0.86

The recovery of Mycobacterium avium complex and Mycobacterium tuberculosis from blood specimens of AIDS patients using the nonradiometric BACTEC NR 660 medium. Am J Clin Pathol (1990) 0.85

Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol (1993) 0.85

Intrathecal bupivacaine with morphine or neostigmine for postoperative analgesia after total knee replacement surgery. Can J Anaesth (2001) 0.85

Activity of purine analogs against Leishmania donovani in vivo. Antimicrob Agents Chemother (1987) 0.85